Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

GE Healthcare’s New Imaging Tech and Intelligent Apps Unveiled at #RSNA19 will Deliver Hundreds of Millions in Cost Savings and Provider Productivity

December 1, 2019


GE Healthcare today launched more than 30 new, imaging intelligent applications and smart devices designed to drive efficiency in radiology departments, aiming to double productivity and cost savings for systems by 2025. For healthcare executives, the new offerings help systems to save costs, improve technology utilization, and increase patient volumes. Clinicians also will benefit from the new technologies through intuitive workflows, improved diagnostic confidence and less rework, allowing them to spend more time with patients.

Healthcare inefficiencies lead to nearly $1 trillion of annual financial waste in the United States alone. 1 Healthcare executives report costs and transparency as their number one concern moving into next year and need new solutions to help solve these challenges. 2 Recognizing the opportunity to reduce waste and increase efficiency across the healthcare industry, GE Healthcare is presenting the following new intelligent applications and smart devices at the 105 th annual meeting of the Radiological Society of North America (RSNA).

“Automation and smart technologies are not only the future of medical imaging but are essential as departments look to transform workflows and the patient experience,” said Dr. Vincent Lombard, the first clinical adopter of Revolution™ Maxima with AI-based Auto Positioning 4, and a radiologist at Centre Imagery Jacques Callot. “By integrating artificial intelligence into existing workflows we’ve been able to not only improve scan quality and reduce steps, but we’ve also been able to spend more time caring for patients.”

Several of the new smart devices and intelligent applications were developed using Edison, GE Healthcare’s secure intelligence platform that helps both GE Healthcare developers and select strategic partners to design, develop, manage, secure and distribute advanced applications, services and AI algorithms quickly. Updates to GE Healthcare’s portfolio follow the launch of the Edison Developer Program which expands the Edison ecosystem to accelerate the adoption and impact of advanced applications and developer services across health systems. The Edison Developer Program helps healthcare providers gain easier access to market-ready algorithms and applications by directly integrating these technologies into existing workflows.

“Now, more than ever, clinicians face tremendous pressure to deliver optimal patient care and clinical outcomes with fewer resources,” said Kieran Murphy, President and CEO of GE Healthcare. “By integrating data, intelligent software applications, and smart devices, we’re enabling clinicians to make faster, more informed decisions to give them time with what matters most: their patients.”

GE Healthcare is showcasing its efficiency-focused applications and devices at RSNA in the South Hall, Booth 4133. The full GE Healthcare RSNA 2019 press kit can be found here.

About GE Healthcare

GE Healthcare is the $19.8 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world. Follow us on Facebook, LinkedIn, Twitter and Insights for latest news, or visit our website https://corporate.gehealthcare.com/ for more information .

Certain statements in this press release are forward-looking. Any descriptions of future functionality reflect current product direction, are for informational purposes only, and do not constitute a commitment to provide specific functionality. Timing and availability are subject to change and applicable regulatory approvals.


3 510(k) pending at FDA. Not available for sale in the United States.
4 GE Healthcare Data on File.
5 510(k) pending at FDA. Not available for sale in the United States.
6 Embo ASSIST solution includes FlightPlan For Embolization, Vision 2, VesselIQ Xpress, Autobone Xpress and requires AW workstation with Volume Viewer, Volume Viewer Innova. These applications are sold separately. FlightPlan for Embolization is 510(k) pending at FDA. Not available for sale in the United States.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191201005114/en/

CONTACT: GE Healthcare Media Contact

Kate Rodgers


+1 (262) 202–5430



SOURCE: GE Healthcare

Copyright Business Wire 2019.

PUB: 12/01/2019 07:00 AM/DISC: 12/01/2019 07:00 AM